NGS Webinar

On-Demand Webinar Topic:

 

Gene-Characterized FFPE Tissues for Validation and Discovery on June 9th

 

Register for it and we'll send you the recorded talk!

 

 

This webinar will be pre-recorded for our international customers. A Youtube link will be emailed to you on June 9th to view the webinar.

 

Keep an eye out for it!

 

Please send us questions that you would like to be addressed during the webinar at info@biochain.com

 

Talk to an expert

American Society of Human Genetics (ASHG) 2020 Virtual Meeting

BioChain Institute, Inc. is proud to present an abstract at the American Society of Human Genetics (ASHG) 2020 Virtual Meeting.

The ASHG 2020 Virtual Meeting is held on Oct. 27-30, 2020. For more information, please visit ASHG.

Talk to an expert

BioChain Introduces New Lines of HPV and Microsatellite instability (MSI) Characterized FFPE Tissue Products

To expand its characterized tissue product line, BioChain proudly introduces HPV Characterized and MSI Characterized FFPE tissue products.

FFPE HPV Characterized

HPV infection has been reported to correlate with several cancer types, especially squamous cell carcinomas originating from head and neck (H&N) as well as cervix tissues. HPVs are classified by genotype, and at least 130 types have been identified by sequencing the gene encoding the major capsid protein L1. High-risk genotypes 16 and 18 are associated with 70% of cervical, and about 80% HPV positive vulval and vaginal carcinoma. Using Diacarta’s QuantiVirus HPV E6/E7 RNA test, BioChain offers HPV-characterized H&N and cervix squamous cell carcinoma tissue sections from various donors as control slides for scientists in this field of study.  Both positive and negative samples are available. Please follow the link below to learn more.

https://www.biochain.com/products/tissue/ffpe-hpv-characterized/

FFPE MSI Characterized

Microsatellite instability (MSI) is the condition of genetic hypermutability (predisposition to mutation) that results from impaired DNA mismatch repair (MMR). MSI is associated with a plethora of cancer types, including colorectal, gastric, endometrium, ovarian, hepatobiliary tract, urinary tract, brain, and skin cancers. However, MSI is most prevalent in association with colon cancer. BioChain has characterized many of these cancer samples using either direct PCR or indirect immunohistochemistry (IHC) with MLH-1, PMS2, MSH-2, and MSH-6 antibodies to give these control samples to the cancer research community. Please follow the link below to learn more.

https://www.biochain.com/products/tissue/ffpe-msi-characterized/

 

Talk to an expert

American Society of Human Genetics 2019 Annual Meeting

American Society of Human Genetics ASHG 2019

American Society of Human Genetics (ASHG) 2019 Annual Meeting
Booth# 1608
George R. Brown Convention Center
Houston, TX
October 16-18

Join BioChain Institute Inc. at the ASHG 2019 taking place at the George R. Brown Convention Center in Houston, Texas.

The American Society of Human Genetics Annual Meeting is held each fall in a major U.S. or Canadian city and attracts over 7,000 scientific attendees, plus almost 250 exhibiting companies, which makes it the world’s largest gathering of human genetics professionals. It’s all happening at the George R. Brown Convention Center October 16-18, 2019!

Stop by our booth with any questions or contact us to set up a time to meet while in Houston. Let’s talk about your upcoming genetic testing projects.

Find out what BioChain has to offer in the way of DNA, RNA extracts to the human genetics research community. BioChain also provides kits and instrumentation for nucleic acid purification.

 

 

Talk to an expert

ISHI Annual Meeting 2019

ISHI Annual Meeting 2019

ISHI (International Symposium on Human Identification)
Booth # 115
Palm Springs Convention Center
Palm Springs, CA
September 23-26, 2019

Join BioChain Institute Inc. at the ISHI 2019 taking place at the Palm Springs Convention Center in Palm Springs, California.

The ISHI is the largest annual meeting focusing entirely on DNA forensics. Discover the newest advances in DNA technology from top experts in the field at The 30th International Symposium on Human Identification. It’s all happening at the Palm Springs Convention Center September 23-26, 2019!

Stop by our booth with any questions or contact us to set up a time to meet while in Palm Springs. Let’s talk about your upcoming forensic sample preparation projects.

Find out what BioChain has to offer in the way of DNA, RNA extracts to the forensic research community. BioChain also provides kits and instrumentation for nucleic acid purification.

Talk to an expert

ASCO Annual Meeting 2019

May 31- June 4, 2019
McCormick Place
Chicago, Illinois

Join BioChain Institute Inc. at the ASCO Annual Meeting 2019 taking place at the McCormick Place in Chicago, Illinois.

The ASCO Annual Meeting is considered the world’s premier oncology conference, organized by the American Society of Clinical Oncology. Every year, the ASCO conference brings together more than 35,000 oncologists from all around the globe, and is attended by all medical, educational and industrial stakeholders involved in the field of oncology worldwide.

Stop by our booth with any questions or contact us to set up a time to meet while in Chicago. Let’s talk about your upcoming life sciences and oncology projects.

Find out what BioChain has to offer in the way of tissues, DNA, RNA, protein extracts to the biopharma and research community (including NGS-characterized tumor sections). BioChain also provides kits and instrumentation for nucleic acid purification that are suitable for liquid biopsy and other purposes, such as Biochain's cfPure® V2 Cell-Free DNA Extraction kits.

Talk to an expert

BioChain Responds to Epigenomics’ unilateral termination of license contract

March 12, 2019

Newark, CA

BioChain, a US-based company, said today Epigenomics AG of Germany seriously violated the terms of an ongoing licensing contract by publicly announcing on March 6, 2019 the unilateral termination of BioChain’s licensing right of Septin9 marker in China. The termination of the contract by Epigenomics is not legally effective.

BioChain’s CEO, Grace Tian stated that according to the terms of the contract, disputes between the two parties require the parties to go through a mediation and arbitration process.  BioChain filed a request with the contractually specified mediation and arbitration center on March 1, 2019 in accordance with the contract, before Epigenomics unilaterally terminated the contract.

BioChain and its affiliates, as the exclusive licensee of Septin9 marker in China, have diligently worked to expand its market position despite challenging market conditions, including the fact that one relevant patent of Epigenomics was invalidated in China and the news was publicly published in May 2018.

Tian said, “Epigenomics’ termination of the Septin9 contract has incurred damages to BioChain’s reputation and investment and BioChain will take further legal actions to protect its interests”.

Contact:

Company: BioChain Institute Inc. 39600 Eureka Drive, Newark, CA 94560, Tel 510-783-8588, Email info@biochain.com

 

Talk to an expert

UCSD Research Supplier Product Show

Join our product specialist Sandy Mavi from BioChain Institute Inc. at the Research Supplier Product Show taking place at the University of California San Diego .

Find out what BioChain’s products have to offer in the way of tissues, DNA and RNA sequencing, PCR and RT-PCR, liquid biopsy kit, gene expression analysis, DNA and RNA purification, protein extraction and purification, and protein expression analysis. BioChain’s One-Stop Services for Next Generation Sequencing, from clinical sample collection, sample preparation, sequencing to bioinformatics analysis, will revolutionize the industry.

Show Details

July 26, 2018
11:00A - 1:30P
University of California, San Diego
Location: Price Center
9500 Gilman Drive
La Jolla, CA

Talk to an expert

AACR Annual Meeting 2018

April 15-18, 2018
McCormick Place North/South
Chicago, Illinois

Join BioChain Institute Inc. at the AACR Annual Meeting 2018 taking place at the McCormick Place North/South in Chicago, Illinois.

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.

Stop by our booth with any questions or contact us to set up a time to meet while in Chicago. Let’s talk about your upcoming life sciences and oncology projects.

Find out what BioChain has to offer in the way of tissues, DNA, RNA, protein extracts to the biopharma and research communities (including NGS-characterized tumor sections). BioChain also provides kits and instrumentation for nucleic acid purification that are suitable for liquid biopsy and other purposes.

Talk to an expert

Cleveland Clinic Foundation Research Supplier Product Show

APR 12, 2018

Cleveland Clinic Foundation
Lerner Research Institute, Garden Hallway
9620 Carnegie Avenue
Cleveland, Ohio 44195Join BioChain Institute Inc. at the Cleveland Clinic Foundation Research Supplier Product Show taking place at the Lerner Research Institute, Garden Hallway. Visit our booth at this popular LSE Event at the  Cleveland Clinic Lerner Research Institute  and meet with  Vidyodhaya Sundaram Ph.D, MBA an alumni from Cleveland Lerner center to learn more about our life science research products.

 

Talk to an expert